Business Context and Reporting Period
This Form 8-K is filed by Integrity Applications, Inc. (not Glucotrack, Inc.) for the reporting period ending December 31, 2018. The filing details a significant capital structure event approved by shareholders on December 21, 2018, involving the forced conversion of Series A, B, and C Preferred Stock into common stock.
Key Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on equity instrument adjustments.
- Forced Conversion Price: $0.258 per share (lower of $1.00 or 45-day volume weighted average price).
- Private Placement (D Round): $6,154,000 raised since December 1, 2017, with $3,846,000 remaining to be sold. The purchase price for these shares was reset from $4.50 to the Forced Conversion Price, resulting in the issuance of additional shares to investors.
- Warrant Restructuring: Existing warrants from Rounds A, B, C, and D were cancelled and replaced with three new warrants per unit at exercise prices of $1.80, $3.60, and $5.40.
- AGI Warrants: Warrants issued to Andrew Garrett, Inc. were adjusted via full ratchet provisions, decreasing the exercise price and increasing the warrant count proportionately.
Material Changes Versus Prior Period
The primary material change is the dilution of the share count due to the forced conversion and price reset mechanisms.
- Basic Shares Outstanding: 141,502,005 common shares.
- Fully Diluted Shares: 220,466,422 shares (including warrants and options).
- Instrument Conversion: Preferred stock instruments were converted to common stock, and warrant terms were fundamentally altered to reflect the new lower conversion price.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future revenue guidance, operational outlook, or specific risk factors beyond the immediate impact of the capital restructuring. The event represents a significant dilutionary event for existing shareholders due to the reset of issuance prices and the forced conversion of preferred equity.
Investor Verification Checklist
- Verify the exact number of new shares issued to D Round investors to calculate total dilution.
- Confirm the updated fully diluted share count post-conversion against the 220,466,422 figure cited.
- Review the specific terms of the new warrants ($1.80, $3.60, $5.40) to assess future dilution potential.
- Check subsequent filings for the impact of this conversion on the company's cash position and working capital.
- Clarify the discrepancy between the requested company name (Glucotrack, Inc.) and the filing registrant (Integrity Applications, Inc.).